Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Zanten, S J O V.
Right arrow Articles by Zinsmeister, A R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Zanten, S J O V.
Right arrow Articles by Zinsmeister, A R
Gut 1999;45(Suppl 2):II69-II77 ( September )

Design of treatment trials for functional gastrointestinal disorders

S J O Veldhuyzen van Zantena, N J Talleyb, P Bytzerc, K B Kleind, P J Whorwelle, A R Zinsmeisterf

a Chair, Committee on Design of Treatment Trials for Functional Gastrointestinal Disorders, Multinational Working Teams to Develop Diagnostic Criteria for Functional Gastrointestinal Disorders (Rome II), Division of Gastroenterology, Dalhousie University, Halifax, Canada, b Co-Chair, Committee on Design of Treatment Trials for Functional Gastrointestinal Disorders, Multinational Working Teams to Develop Diagnostic Criteria for Functional Gastrointestinal Disorders (Rome II), Department of Medicine, University of Sydney, Nepean Hospital, New South Wales, Australia, c Department of Medical Gastroenterology, Glostrup University Hospital, Glostrup, Denmark, d International Drug Development Consulting, Bainbridge Island, Washington, USA, e Department of Medicine, University Hospital of South Manchester, Manchester, UK, f Section of Biostatistics, Mayo Clinic, Rochester, MN, USA

Correspondence to: S J O Velduyzen van Zanten, MD, Queen Elizabeth II Health Sciences Center, Victoria General Hospital Site, Room 928, Centennial Building, 1278 Tower Road Halifax, Nova Scotia B3H 2Y9, Canada. Email: zanten{at}is.dal.ca

Until recently many clinical trials of functional gastrointestinal disorders (FGIDs) suffered from important weaknesses in trial design, study execution, and data analysis. This makes it difficult to determine whether truly efficacious therapies exist for these disorders. One of the important methodologic problems is the absence of validated outcome measures and lack of consensus among stakeholders on how to measure outcome. Currently much of the effort is being put into the development of validated outcome measures for several of the FGIDs. The randomized, controlled trial with parallel groups is the design of choice. In this report, guidelines are given for the basic architecture of intervention studies of FGIDs. Further studies on design issues are required to ensure the recommendations will become evidence based in the future.


Keywords: clinical trial; random allocation; functional gastrointestinal disorder(s); dyspepsia; functional dyspepsia; irritable bowel syndrome; evidence based medicine; study design; outcome measures; Rome II


© 1999 by Gut



This article has been cited by other articles:


Home page
GutHome page
S. J O Veldhuyzen Van Zanten
Pitfalls in designing trials of functional dyspepsia: the ascent and demise of itopride
Gut, June 1, 2008; 57(6): 723 - 724.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. Pimentel, S. Park, J. Mirocha, S. V. Kane, and Y. Kong
The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial.
Ann Intern Med, October 17, 2006; 145(8): 557 - 563.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
D. E. Baker
Rationale for using serotonergic agents to treat irritable bowel syndrome
Am. J. Health Syst. Pharm., April 1, 2005; 62(7): 700 - 711.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
T. M. Ball and J. A. Weydert
Methodological Challenges to Treatment Trials for Recurrent Abdominal Pain in Children
Arch Pediatr Adolesc Med, November 1, 2003; 157(11): 1121 - 1127.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
Discussion II
Gut, May 1, 2002; 50(90004): iv31 - 32.
[Full Text] [PDF]


Home page
GutHome page
P Bytzer
H2 receptor antagonists and prokinetics in dyspepsia: a critical review
Gut, May 1, 2002; 50(90004): iv58 - 62.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
F. Creed, J. Ratcliffe, L. Fernandez, B. Tomenson, S. Palmer, C. Rigby, E. Guthrie, N. Read, and D. Thompson
Health-Related Quality of Life and Health Care Costs in Severe, Refractory Irritable Bowel Syndrome
Ann Intern Med, May 1, 2001; 134(9_Part_2): 860 - 868.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 BMJ Publishing Group Ltd & British Society of Gastroenterology